Cathie Wood's ARK ETFs have made a series of significant trades on Friday, February 14, 2025, continuing their dynamic investment strategy in the tech and biotech sectors. The most notable move was ...
Brent Sabatini, the Senior Vice President and Chief Accounting Officer at Vir Biotechnology, Inc. (NASDAQ:VIR), recently sold 1,562 shares of the company's common stock. According to InvestingPro data ...
Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...
All high schools, including Elliot Alternative, offer the design, visual and media arts pathway. Davis, Downey, Gregori and ...
Tether’s acquisition of a minority stake in Juventus broadens its portfolio by incorporating digital assets, AI, and biotech ...
Tether invests in Juventus, driving JUV token growth and expanding blockchain in sports after its EU exit due to stablecoin regulations.
Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
Cornerstone Research recently issued its 2024 Year in Review report examining recent trends in securities class action filings. For the second year ...
Moderna’s consensus price target has significantly declined from $119.26 to $47.5, indicating a cautious outlook from ...
Fortis Healthcare has signed definitive agreements to acquire Shrimann Superspecialty Hospital in Jalandhar, Punjab for Rs ...
Two biotechs say they’re using AI to conjure drugs from scratch. Their documents suggest otherwise
A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedicines routinely aggrandize their AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback